A detailed history of Semanteon Capital Management, LP transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Semanteon Capital Management, LP holds 149,156 shares of FOLD stock, worth $1.33 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
149,156
Previous 105,868 40.89%
Holding current value
$1.33 Million
Previous $1.13 Billion 24.27%
% of portfolio
0.75%
Previous 0.77%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$9.36 - $12.01 $405,175 - $519,888
43,288 Added 40.89%
149,156 $1.41 Billion
Q3 2024

Oct 24, 2024

BUY
$9.55 - $12.09 $1.01 Million - $1.28 Million
105,868 New
105,868 $1.13 Billion

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.5B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Semanteon Capital Management, LP Portfolio

Follow Semanteon Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Semanteon Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Semanteon Capital Management, LP with notifications on news.